Bayer Leverkusen’s Midfield Hope Kennet Eichhorn Battles Illness
Bayer Leverkusen’s Great Midfield Hope Sidelined as Eichhorn Battles Metabolic Illness
The plan was simple. Kennet Eichhorn would arrive as the next big thing, slide into Bayer Leverkusen’s midfield and grow inside one of Europe’s most finely tuned systems. Instead, before he has even kicked a ball for the club, the 17-year-old finds himself in a hospital bed, fighting an illness that has abruptly stalled one of the most exciting rises in German football.
In mid-July, Eichhorn lost five kilos in just five days due to a gastrointestinal infection. What initially looked like an aggressive but ordinary bug has turned into something far more serious. Doctors have now diagnosed a metabolic illness, and the new signing is receiving inpatient treatment as specialists search for the exact cause and work on rebuilding his strength.
For Leverkusen, this is no short pause. According to Sport Bild, the club is preparing for a lengthy spell without the teenager. There is no timetable for his return, no soft target date to circle on the calendar. Internally, Leverkusen have removed Eichhorn from their squad planning for the entire first half of the season.
That single medical bulletin has reshaped an entire transfer strategy.
Midfield Plans Torn Up
Leverkusen had originally expected to move on two central midfielders this summer. The logic was clear: Eichhorn, one of Europe’s standout young talents, would arrive and gradually be integrated, freeing the club to cash in on depth in a crowded area of the pitch.
Now the club will only sanction the sale of one midfielder. Three names sit on the list: Equi Fernandez (24), Aleix Garcia (29) and Robert Andrich (31).
Fernandez currently looks the likeliest to go. He has the strongest market and could bring in around 20 million euros. The relationship dynamics around him have shifted as well. After falling out with former coach Kasper Hjulmand, Fernandez now appears to have repaired his standing under Carles Martinez, a factor that gives Leverkusen at least some leverage as they weigh sporting value against financial opportunity.
Garcia, for his part, is open to a move. He can imagine a new challenge, but the market has not quite responded. Suitable suitors are said to be lacking so far, and without the right offer, Leverkusen will not force the issue.
That leaves Andrich. At 31, he is the veteran presence in the group, a known quantity in a team chasing trophies on multiple fronts. As things stand, all signs point to him staying. With Eichhorn unavailable, his experience and reliability suddenly feel less like a luxury and more like a necessity.
From Hertha Breakthrough to Sudden Halt
Eichhorn’s situation stings because of how fast his stock had been rising.
Last season, he established himself as a regular for Hertha BSC in the 2. Bundesliga. Still a teenager, he played with the poise of a seasoned professional, even if his campaign carried the rough edges of youth: an ankle injury that kept him out at times, and a suspension following a red card. The talent, though, was never in doubt.
Clubs across Europe lined up. Bayern Munich watched him. Liverpool and Manchester City tracked him. Real Madrid and Paris Saint-Germain were in the conversation. For a 17-year-old operating in Germany’s second tier, that level of interest said everything.
Leverkusen moved decisively, paying nine million euros to bring him in. It was a fee that underlined both their belief in his ceiling and their confidence in their own development model. In a squad already rich in young quality, Eichhorn was supposed to be the next carefully sculpted project.
Instead, the club now has to wait.
The diagnosis of a metabolic illness shifts the focus away from tactics and minutes and onto something more fundamental: health. The priority is no longer how quickly Eichhorn can adapt to the Bundesliga, but how fully he can recover his strength and stability.
For Leverkusen, that means patience. For Eichhorn, it means a different kind of fight than the one he expected when he signed his contract.
His breakthrough at the BayArena, once seen as a matter of “when” rather than “if,” is now completely open-ended. The spotlight that had followed him from Hertha to the gates of Europe’s elite has dimmed, but it has not disappeared. It simply waits, like the club, for news from the hospital rather than from the training ground.
